跳至主要内容
临床试验/CTRI/2019/01/017202
CTRI/2019/01/017202已完成2 期

Comparative study of the safety and therapeutic efficacy of oral cyclosporine and oral betamethasone minipulse therapy in the treatment of alopecia areata.

Shibashis Chatterjee0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients consenting for the study.
  • 2.All the patients presenting with circumscribed patch of hair loss without any signs of inflammation or scarring,of size > 3cm in diameter.
  • 3.Patients who have symptoms of 3 months or more duration.
  • 4.Patients who have not taken any other modalities of treatment in the last 3 months.

排除标准

  • 1.Patients who are k/c/o hypertension.
  • 2.Patients with secondary infection.
  • 3.Pregnant and lactating females.
  • 4.Patients with pre-existing renal and liver diseases.
  • 5.Patients with diabetes mellitus.
  • 6.Patients having any Autoimmune disease like SLE, Sjogrenâ??s Syndrome,etc.
  • 7.Patients having contraindications to the drugs used in the study.

研究者

发起方
Shibashis Chatterjee

相似试验